Mineralocorticoids and Hypertension

  • Werner Kaufmann
  • Gerhard Wambach
  • Albert Helber
  • Karl-August Meurer
Conference proceedings

Part of the International Boehringer Mannheim Symposia book series (BOEHRINGER)

Table of contents

  1. Front Matter
    Pages I-XVII
  2. Physiological Basis of Mineralocorticoid Hormone Action

  3. Regulation of Mineralocorticoids

    1. Front Matter
      Pages 27-27
    2. C. R. W. Edwards, E. A. S. Al-Dujaili, B. C. Williams
      Pages 29-40
    3. S. Abdelhamid, P. Vecsei, N. Panitz, H. L. Christl
      Pages 41-50
    4. W. Oelkers, M. Schöneshöfer
      Pages 51-61
    5. P. Vecsei, S. Abdelhamid, P. Bubel, D. Haack, S. Lewicka, K. Lichtwald et al.
      Pages 62-77
  4. Pathophysiological Aspects of Mineralocorticoid Excess

    1. Front Matter
      Pages 79-79
    2. J. Mitchell, D. F. Bohr
      Pages 101-112
    3. B. A. Scoggins, A. Butkus, J. P. Coghlan, D. A. Denton, R. T. Mason, P. J. Meehan et al.
      Pages 113-128
    4. T. Philipp, B. Lüth, G. Wucherer, A. Distler
      Pages 129-139
  5. Clinical Aspects of Mineralocorticoid-induced Hypertension

    1. Front Matter
      Pages 141-141
    2. D. C. Kem, R. D. Brown, R. Painton, C. Hanson, D. Lyons, M. Weinberger et al.
      Pages 155-166
    3. M. Fischer, W. Vetter, M. Galanski, B. Winterberg, H. Vetter
      Pages 167-177
    4. A. Lasaridis, D. L. Davies, C. Beretta-Piccoli, J. J. Brown, R. Fraser, C. Holloway et al.
      Pages 178-186
    5. A. Helber, G. Wambach, W. Hummerich, K. A. Meurer
      Pages 187-196
  6. Antimineralocorticoids

    1. Front Matter
      Pages 197-197
    2. G. Wambach, J. Casals-Stenzel, A. Helber
      Pages 199-207
    3. H. B. Benraad, Th. J. Benraad, W. C. A. M. Buijs, P. W. C. Kloppenborg
      Pages 216-223
    4. J. Hauss, W. Vetter, M. Fischer, H. Vetter
      Pages 224-233
  7. Back Matter
    Pages 235-237

About these proceedings


On behalf of the organizing committee of this symposium, I would like to wel­ come you to Cologne and thank you very much for coming. We appreciate that some of the leading scientists in the field of hypertension have accepted our invi­ tation to participate actively at this conference. Our first symposium on renin-angiotensin, aldosterone, and hypertension took place at Titisee in the Black Forest in 1967. The second one, on the renin-angio­ tensin-aldosterone system under the influence of therapeutic procedures, was held at the same place in 1970. Five years later in 1975 at a third symposium in Cologne, we discussed the problems of central nervous control of sodium balance in relation to the renin-angiotensin system. The symposium about to begin is devoted to the significance of mineralocorti­ coids in developing and sustaining arterial hypertension. 1) In order to provide a physiologic background for the understanding of the mechanisms involved in this complicated process, new concepts on the regulation of mineralocorticoid secretion must be discussed in detail. As the most important mineralocorticoid, aldosterone is regulated by changes in sodium and potassium homeostasis and is also influenced by adrenocorticotropic hormone (ACTH).


Hypertonie Mineralokortikoide hypertension hypertonia kidney

Editors and affiliations

  • Werner Kaufmann
    • 1
  • Gerhard Wambach
    • 1
  • Albert Helber
    • 1
  • Karl-August Meurer
    • 1
  1. 1.Medizinische Klinik Köln-Merheim und Poliklinik der UniversitätKöln 91Federal Republic of Germany

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1983
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-540-12391-0
  • Online ISBN 978-3-642-69081-5
  • Series Print ISSN 0173-0282
  • Buy this book on publisher's site